|
IPO4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.499600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.029600E-01 |
| Normal-vs-Stage2 |
7.118000E-02 |
| Normal-vs-Stage3 |
9.747800E-01 |
| Normal-vs-Stage4 |
5.360600E-01 |
| Stage1-vs-Stage2 |
4.905600E-02 |
| Stage1-vs-Stage3 |
8.230200E-01 |
| Stage1-vs-Stage4 |
5.951200E-01 |
| Stage2-vs-Stage3 |
6.373900E-02 |
| Stage2-vs-Stage4 |
2.899200E-01 |
| Stage3-vs-Stage4 |
5.022200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.881600E-01 |
| Normal-vs-AfricanAmerican |
7.557800E-01 |
| Normal-vs-Asian |
6.086200E-01 |
| Caucasian-vs-AfricanAmerican |
2.898400E-01 |
| Caucasian-vs-Asian |
2.534600E-01 |
| AfricanAmerican-vs-Asian |
8.910800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.971200E-01 |
| Normal-vs-Female |
3.946200E-01 |
| Male-vs-Female |
2.696200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.994000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.742000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.567560E-01 |
| Normal-vs-Age(81-100Yrs) |
6.093200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.809400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.775850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.616800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.077170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.589400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.304200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.627000E-01 |
| Classical-VS-Follicular |
1.334020E-01 |
| Classical-VS-Other |
4.682400E-02 |
| Classical-VS-Normal |
2.407400E-01 |
| Tall-VS-Follicular |
4.525400E-01 |
| Tall-VS-Other |
8.521600E-02 |
| Tall-VS-Normal |
5.667800E-01 |
| Follicular-VS-Other |
2.884000E-01 |
| Follicular-VS-Normal |
6.613800E-01 |
| Other-VS-Normal |
6.578000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.653000E-01 |
| Normal-vs-N1 |
3.806600E-01 |
| N0-vs-N1 |
1.336370E-01 |
|
|
